Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC25A51 pseudogene 2 (SLC25A51P2) is a human genomic locus classified as a pseudogene, meaning it is a non-functional copy of the SLC25A51 gene that is not translated into protein. While its parent gene, SLC25A51, encodes a mitochondrial carrier protein essential for NAD+ transport and mitochondrial metabolism, SLC25A51P2 does not produce a functional protein and lacks known physiological or pathological roles. It may be included in annotation sets and sometimes appears in gene catalogs, but is not considered a therapeutic target or relevant for drug development. The commonly searched SLC25A51 gene (without the "P2") is a functional mitochondrial NAD+ transporter and a potential research target, but SLC25A51P2 is a pseudogene, hence not a true target. There is no evidence that SLC25A51P2 is involved in disease, signal transduction, or any drug interaction. This entry should not be mistaken for the functional SLC25A51 transporter and should not be used for drug discovery or therapeutic targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SLC25A51 pseudogene 2 (SLC25A51P2).